Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lucía Santomé Couto"'
Autor:
María Mar Cutillas-Pérez, Cristina Macía-Rodríguez, Lucía Santomé-Couto, Javier de la Fuente-Aguado
Publikováno v:
Revista Española de Casos Clínicos en Medicina Interna. 5:42-44
La quimioterapia deprime la mielopoyesis y afecta a la integridad de las mucosas gastrointestinales aumentando el riesgo de infecciones sistémicas por translocación de bacterias y hongos. La neutropenia febril es una complicación grave cuya tasa d
Autor:
Rocio Vilchez Simo, Maria Carmen Areses Manrique, María Rosario García Campelo, Cristina Azpitarte Raposeiras, Jose Muñoz Iglesias, Joaquín Martínez, Urbano Anido Herranz, F.J. Afonso, Natalia Fernández Núñez, David Arias Ron, Begoña Campos Balea, Martin Lázaro Quintela, Juan Ruiz Bañobre, Jorge García González, Margarita Amenedo Gancedo, Lucía Santomé Couto, José Luis Fírvida Pérez, Joaquin Casal Rubio, Jesús García Mata, Guillermo Alonso-Jaudenes Curbera, Iria Carou Frieiro
Publikováno v:
Journal of geriatric oncology. 12(3)
Background Nivolumab is an anti PD1 immunotherapy drug approved for advanced Non-Small Cell Lung Cancer (NSCLC) patients who previously received at least one prior line of treatment. Older patients are often not represented in clinical trials and dru
Autor:
Juan Ruiz-Bañobre, José Luis Fírvida Pérez, N. Fernández-Núñez, L. Crama, Martín Lázaro-Quintela, Francisco J. Afonso-Afonso, Pedro Ruiz-Gracia, Jorge García-González, Diego Pérez Parente, Margarita Amenedo-Gancedo, María Del Carmen Areses-Manrique, Lucía Santomé-Couto, Luis León-Mateos, Begoña Campos-Balea, Joaquín Casal-Rubio
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 2093, p 2093 (2020)
Journal of Clinical Medicine
Journal of Clinical Medicine
The combination of programmed cell death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors with chemotherapy has emerged as a promising therapeutic option for advanced non-small-cell lung cancer (NSCLC). The aim of this meta-analysis was to evalu
Autor:
Natalia Fernández Núñez, Martin Lázaro Quintela, Iria Carou Frieiro, Joaquin Mosquera Martinez, Margarita Amenedo Gancedo, Joaquin Casal Rubio, Jose Muñoz Iglesias, Alexandra Sabela Cortegoso mosquera, Rocio Vilchez Simo, Urbano Anido Herranz, Jesús García Mata, Lucía Santomé Couto, Begoña Campos Balea, Mª Carmen Areses Manrique, Jorge García González, Mª Rosario García Campelo, Guillermo Alonso-Jaudenes Curbera, José Luis Fírvida Pérez, Cristina Azpitarte Raposeiras, F.J. Afonso
Publikováno v:
Translational Lung Cancer Research. 7:404-415
Background Recently, immunotherapy has changed the standard of treatment in non-small cell lung cancer (NSCLC). Outside clinical trials, data of real life is lacking. This is an observational study that represents the real world experience with nivol
Autor:
Urbano Anido Herranz, Sergio Vázquez Estévez, Martin Lázaro Quintela, Lucía Santomé Couto, Ovidio Fernandez Calvo, Sonia Maciá Escalante, Luis Leon Mateos, F.J. Afonso
Publikováno v:
Critical Reviews in Oncology/Hematology. 107:119-127
Prostate cancer is the most frequent cancer amongst men. Until recently, only two therapeutic options, initial androgen-deprivation therapy in patients without castration-resistant prostate cancer, with addition of docetaxel when the disease becomes
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.